Главная
Рынки
Графики и идеи
Алготрейдинг
Новости
Store
Брокеры
Скачать
Экономический календарь
Торговые сигналы
Вебтерминал
Нажмите
/
для поиска: @user, $symbol, ...
Поиск
Вход
Создать аккаунт
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
IINN
#3818
Inspira Technologies Oxy B.H.N. Ltd. Ordinary Shares
0.5
8
0.00%
Сектор:
Базовая:
Валюта прибыли:
Дневной диапазон
Годовой диапазон
Дневное изменение
0.00%
Месячное изменение
-27.50%
6-месячное изменение
-49.57%
Годовое изменение
-30.12%
Предыдущее закрытие
0.5
8
Open
0.5
8
Bid
Ask
Low
0.5
8
High
0.5
8
Объем
4
Рынки
Рынок акций США
Здравоохранение
IINN
Open full chart
Financials
Overview
Отчетность
Statistics
Dividends
Quarterly
Annual
Value
Q4, 24
TTM
Key stats
Total common shares outstanding
24.25 M
61.33 M
Valuation ratios
Enterprise value
19.63 M
85.8 M
Price to earnings ratio
-1.7
—
Price to sales ratio
—
—
Price to cash flow ratio
-2.01
—
Price to book ratio
4.37
—
Enterprise value to EBITDA ratio
—
—
Profitability ratios
Return on assets %
-0.05
—
Return on equity %
-0.09
—
Return on invested capital %
—
—
Gross margin %
—
—
Operating margin %
—
—
EBITDA margin %
—
—
Net margin %
—
—
Liquidity ratios
Quick ratio
1.89
—
Current ratio
2.02
—
Inventory turnover
—
—
Asset turnover
—
—
Solvency ratios
Debt to assets ratio
—
—
Debt to equity ratio
—
—
Long term debt to total assets ratio
—
—
Long term debt to total equity ratio
—
—
Per share metrics
Operating cash flow per share
-0.02
—
EBIT per share
—
—
EBITDA per share
—
—
Total debt per share
—
—
Cash per share
0.31
—
Net current asset value per share
0.37
—
Tangible book value per share
0.23
—
Working capital per share
0.19
—
Book value per share
0.23
—
Новости
Inspira Technologies hisseleri, sıvı biyopsi genişleme planını açıkladıktan sonra yükseldi
Inspira Technologies stock rises after outlining liquid biopsy expansion plan
Inspira Technologies sıvı biyopsi satın alma stratejisini açıklıyor
Inspira Technologies outlines liquid biopsy acquisition strategy
Inspira Technologies 49,5 milyon dolarlık sipariş onayını yeniledi
Inspira Technologies reaffirms $49.5 million in purchase orders
Inspira Technologies secures Japanese patent for dual lumen cannula
Inspira Technologies 30 Aralık’ta yıllık ve olağanüstü hissedar toplantısı düzenleyecek
Inspira Technologies schedules annual and extraordinary shareholder meeting for December 30
Inspira completes clinical study for HYLA blood sensor with high accuracy
Inspira Technologies hisseleri BAE’ye düzenleyici başvuru sonrası yükseldi
Inspira Technologies stock rises after UAE regulatory submission